Arena Pharmaceuticals (NASDAQ:ARNA) upgraded to Overweight from Neutral, target, at JPMorgan. The stock closed yesterday at .93 on volume of 58748800 shares, above average daily volume of 3508621. Arena Pharmaceuticals is currently above its 50-day moving average of .22 and above its 200-day moving average of .42. SmarTrend is bullish on shares of ARNA and our subscribers received an Uptrend alert on July 01, 2010 at .47, which has returned 13.3% to date. Video Rating: 5 / 5
Clash of the Tech Titans on NASDAQ (MSFT, LEDS, UCTT, ARNA, URBN)
s US division, reported that the US Food and Drug Administration approved their resubmitted latest drug application for antiobesity drug lorcaserin, surging Arena;s shares higher 8.7% on Tuesday. Shares of Arena were trading down -4.00% to 1.68 on … Read more on Galaxy Stocks
www.StockMarketFunding.com Pre-Market Stock Futures Nasdaq Futures Stock Market Upgrades & Downgrades 9 “nasdaq futures” futures “fair value” pre-market premarket “stock trading” “stock market” open video “S&P 500″ Equity futures are higher this morning, but have given up a decent portion of their strong overnight gains (S&P futures are now +8 vs. fair value after trading up 14 pts overnight; DJ futures are +55). There doesn’t seem to be any news to account for the pullback from overnight highs, but it does correspond with a rebound in the dollar and a rally in treasuries. Several positive developments in the tech sector helped the tone in after-hours and led to strong gains overseas. Asian stocks were mostly higher overnight (Nikkei +1.2%, Hang Seng +1.3%, Shanghai -0.2%) and European stocks are showing broad gains at mid-day (FTSE +0.6% , DAX +0.8%, CAC +0.7%), but have also pulled back from highs. Japanese Prime Minister Kan kept his Finance Minister in place, implying that the current FX policy is intact. There was no evidence of any intervention although the Yen is slightly lower vs USD so far, helping boost Japanese exporters again. There are several pieces of positive corporate news helping the tone, primarily with regard to the tech sector. ORCL is trading +4.3% after reporting strong earnings after the close yesterday and giving positive guidance on the subsequent conference call. RIMM is +4.9% after delivering a strong quarter and guidance, and directly …
JP Morgan Biotech Confab Live Chat … Pharmaceuticals(IDIX) after I tweeted about a conversation I had with a Hep C bull who predicted a $ 3 billion takeout by Merck(MRK). Arena Pharmaceuticals(ARNA) made news today with the acceptance of the FDA resubmission of its obesity drug lorcaserin. Read more on TheStreet.com
